23rd American Pharma & Biotech Project, Program and Portfolio Conference

Welcome to the 23rd American Pharma&Biotech Project, PPM Conference!

Portfolio prioritization, decision analysis, agile capacity management, resource forecasting, risk mitigation, and overall strategic decision-making are becoming increasingly difficult in today’s ever-changing pharma R&D landscape. Why summits’s PPM World Tour presents 23rd American Pharma And Biotech Project, Program And Portfolio Management Conference, 3 days of high-level content, interactive discussions and networking, breakout roundtables, 1:1 meetings, and much more!

Attendees will leave with new tools and organizational strategies to optimize portfolio insights and decision-making; and align resource planning, allocation, and capacity management with portfolio prioritization.

Mark your calendar and join us for this game-changing event that will redefine your approach to project, program, and portfolio management in the biopharma industry.

Reasons to attend

Friendly and highly stimulating atmosphere in a smaller circle (around 150 attendees per conference)
Workshops and Roundtables for a deeper dive into important topics in the Pharma industry now
Fun icebreaking social events every evening with delegates, speakers and sponsors of the event
Sharing new ideas and building strong connections
Creative and inspiring platform for fruitful discussion
Big & SME Pharma and Biotech companies

Conference Themes

Wednesday October 16, 2024

Improved Decision Making
Deciding On The Right Mix Of Therapeutic Areas
Assessing Portfolio Risk
Decision Analysis And Structured Decision Making
Break-Out Sessions

Thursday October 17, 2024

Governance And Risk Management
Leadership And Strategic Program Management In Innovative Industries
Aligning Project And Program Execution To Corporate Strategy
Break-Out Sessions

Friday October 18, 2024

Capacity Planning In A Resource-Constrained Environment
Resource Forecasting And Capacity Management Ecosystem
Cell & Gene Therapy Resource Planning And New Modalities
Break-out Sessions

In the Chair

Day 1

Anita Burrell
Anita Burrell is a dynamic consultant in the pharmaceutical industry with over 25 years of experience. She leads Anita Burrell Consulting LLC, focusing on improving patient outcomes through pharmaceutical innovation. Anita is a recognized speaker on health technology assessment, health economics, outcomes research, market access, and digital health. She chairs ISPOR's Digital Health SIG and serves on the Global Committee Council of the Healthcare Businesswomen's Association. Her previous roles include Senior VP at EVERSANA and various leadership positions at Sanofi. Anita has a strong background in health economics and market access strategy.

Day 2 & Day 3

Courtland LaVallee
Corky has worked in the biopharmaceutical project management industry since 1998, where he started as the PM for the Viagra program at Pfizer. Corky joined Genentech in March 2006 as the Director of Development Project Management, tasked with creating from scratch a project management capability focused on supporting drug development teams. He has since held PM leadership positions at companies such as Onyx, Theravance and BeiGene, and most recently was a Global Program Director at EQRx. He also taught the New Drug Development and Lifecycle Management public course for DIA. Corky has spoken at many conferences and edited the recently released Project Manager for Drug Developers, published by CRC Press and written by several talented practitioners of the art (who coincidentally are at this conference!) Corky is now retired but actively considering his options.

Contact us

SPEAKING

Simona Marcekova

e-mail - simona.marcekova@whysummits.com
LinkedIn - Simona Marcekova

SPONSORING

Srihari Kamban

e-mail - shk@whysummits.com
LinkedIn - Srihari Kamban

SPONSORING

Dave Baruah

e-mail - dave.baruah@whysummits.com
LinkedIn - Dave Baruah

ATTENDING

Liza Zhaivoronok

e-mail - liza.zhaivoronok@whysummits.com
LinkedIn - Liza Zhaivoronok